Manufacturer record
Zeta Formulation Private Limited: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
3 batches manufactured by Zeta Formulation Private Limited were declared Not of Standard Quality between November 2025 and June 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
3 records linked to Zeta Formulation Private Limited in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Azithromycin Oral Suspension IP | 26150Mfg 2026-03 · Exp 2028-02 | pH and ContentpH | DTL, Chennai-06State lab | Jun 2026 |
| Ambroxol Hydrochloride, Terbutaline Sulphate, Guaiphenesin And Menthol Syrup | MZYA02Mfg 2025-01 · Exp 2026-12 | ContentOther | Drugs Testing Laboratory, Chennai-06State lab | Jan 2026 |
| Ambroxol Hydrochloride, Guaiphenesin, Terbutaline Sulphate and Menthol Syrup | 24338Mfg 2024-11 · Exp 2026-10 | ContentOther | Drugs Testing Laboratory, Chennai-06State lab | Nov 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.